Literature DB >> 6244768

Calcium and phosphate metabolism in tumoral calcinosis.

P D Mitnick, S Goldfarb, E Slatopolsky, J Lemann, R W Gray, Z S Agus.   

Abstract

We have recently seen a patient with tumoral calcinosis, a syndrome comprising hyperphosphatemia, normocalcemia, normal glomerular filtration rate (GFR), and extensive periarticular calcific masses. Parathyroid hormone (PTH) deficiency or target organ resistance was ruled out by demonstration of normal serum PTH and urinary 3'5'cyclic AMP excretion and normal response to exogenous PTH and to endogenous stimulation by ethylenediaminetetraacetate. An intrinsic proximal tubular defect allowing enhanced renal PO4 reabsorption was probably present because there was no phosphaturic response to acetazolamine and renal PO4 threshold remained abnormally elevated even after PTH infusion. We then studied the mechanism by which serum calcium level is maintained in the normal range despite hyperphosphatemia and absence of secondary hyperparathyroidism. Normal 1,25-(OH)2 vitamin D was found, suggesting normal gastrointestinal calcium absorption. This, combined with markedly reduced urinary calcium excretion, perhaps a direct effect of hyperphosphatemia, may maintain calcium balance and prevent secondary hyperparathyroidism. A rise in urinary cyclic AMP excretion after furosemide-induced calciuria supports this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244768     DOI: 10.7326/0003-4819-92-4-482

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

1.  CASE REPORT Idiopathic Tumoral Calcinosis of the Nontraumatic Thumb.

Authors:  Ginard I Henry; Chad M Teven
Journal:  Eplasty       Date:  2012-06-18

2.  An ocular presentation of familial tumoral calcinosis.

Authors:  Emer McGrath; Fiona Harney; Frank Kinsella
Journal:  BMJ Case Rep       Date:  2010-09-20

3.  Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

Authors:  A Metzker; B Eisenstein; J Oren; R Samuel
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

4.  A man with an enlarging foot mass.

Authors:  Ali Zahrai; Deloar Hossain; John M Embil; Elly Trepman
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

5.  A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.

Authors:  David E Leaf; Myles Wolf
Journal:  Am J Kidney Dis       Date:  2012-08-30       Impact factor: 8.860

6.  Hyperphosphatemia is prevalent among children with nephrotic syndrome and normal renal function.

Authors:  Sofia Feinstein; Rachel Becker-Cohen; Choni Rinat; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2006-08-08       Impact factor: 3.714

7.  Uraemic tumoural calcinosis.

Authors:  Muhsen Al-ani; Konstantinos Parperis; Christina DeBaun Kelly
Journal:  BMJ Case Rep       Date:  2016-02-24

8.  Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis.

Authors:  R Candrina; B Cerudelli; V Braga; A Salvi
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

9.  Tumorous calcinosis: a disease of its own?

Authors:  W Braun; E Mayr; K Kundel; A Rüter
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

10.  Case report 500: Tumoral calcinosis in area of left hip.

Authors:  M Zawin; L D Katz; J P Lawson
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.